The influence of differences in solvents and concentration on the efficacy of propofol at an induction of anesthesia

The influence of differences in solvents and concentration on the efficacy of propofol at an induction of anesthesia - The differences in solvents and concentration of propofol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019925

Enrollment

Registered

2015-11-25

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical case

Interventions

The patients of group D1 were received AstraZeneca Diprivan 1% at a rate of 40 mg/kg/h. Group M1 was administered 1%-Maruishi and group M2 was administered 2%-Maruishi at the same rate of propofol. Th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Surgical patients.

Exclusion criteria

Exclusion criteria: The patients with severe preoperative complications.

Design outcomes

Primary

Measure	Time frame
The required dose of propofol at the induction of anesthesia.	—

Countries

Japan

Contacts

Public ContactYushi Adachi

Hamamatsu University School of Medicine Intensive Care Unit

yuadachi.ccm@hama-med.ac.jp053-436-2286

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026